Circulating Tumor DNA (ctDNA)-Guided Late-Line Treatment in Patients With Late-Stage Breast Cancer
Clinical trial NCT05427617 · COMPLETED
Trial details
- NCT number
- NCT05427617
- Sponsor
- Hunan Cancer Hospital
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2016-12-01
- Primary completion
- 2019-06-30
- Enrollment
- 223
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.